MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Meta-Analysis of Short-afferent inhibition and Cognitive Impairment in Parkinson’s Disease

J.F. Martin-Rodriguez, P. Mir (Seville, Spain)

Meeting: 2018 International Congress

Abstract Number: 1268

Keywords: Acetylcholine, Cognitive dysfunction, Transcranial magnetic stimulation(TMS)

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Cognition

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: In this meta-analysis, we assess whether short-afferent inhibition (SAI) is impaired in Parkinson’s disease (PD) patients as well as identify clinical variables associated to SAI magnitude in PD. We further assess the potential value of SAI as a marker of cognitive impairment in PD, and its association with four specific cognitive domains.

Background: Research over the past 20 years has shed light on the involvement of the cholinergic system in PD. SAI is characterized by the suppression of the transcranial magnetic stimulation motor evoked potential by the cortical arrival of a somatosensory afferent volley. SAI is widely considered a non-invasive measure of sensori-motor integration, and has emerged as a putative neurophysiological marker of cholinergic function in the human brain.

Methods: Pubmed and PsyINFO were consulted to identify all studies that compared SAI between PD patients and healthy controls. Separated meta-analyses comparing 1) PD patients vs. healthy controls 2) patients with cognitive impairment vs patients with preserved cognitive functions were conducted, using the random effects model. Analysis of heterogenity followed by moderator analysis for dichotomous moderator and meta-regression were performed.

Results: A moderate-to-severe reduction in SAI was observed in PD patients (Figure 1). Furthermore, through moderator analysis, the impairment of SAI was shown to be associated with disease duration and therapeutic state. Patients under dopaminergic agents (“on” state) displayed worse SAI than those after dopaminergic agent withdrawal (“off”). Our meta-analysis also revealed that patients with cognitive impairment displayed significantly lower levels of SAI than those without cognitive impairment (Figure 2a). Cognitive domains associated to worse SAI include visuospatial/visuoperceptive and executive functions (Figure 2b).

Conclusions: This study highlights the importance of assessing SAI as a neurophysiological marker associated to cognitive deficits in PD.

To cite this abstract in AMA style:

J.F. Martin-Rodriguez, P. Mir. Meta-Analysis of Short-afferent inhibition and Cognitive Impairment in Parkinson’s Disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/meta-analysis-of-short-afferent-inhibition-and-cognitive-impairment-in-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/meta-analysis-of-short-afferent-inhibition-and-cognitive-impairment-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley